Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on cardio-ankle vascular index (CAVI) in type 2 diabetic patients with hypertension

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 5, 2009, Pages 621-626

  Miyashita, Yoh ^a   Saiki, Atsuhito ^a   Endo, Kei ^a   Ban, Noriko ^a   Yamaguchi, Takashi ^a   Kawana, Hidetoshi ^a   Nagayama, Daiji ^a   Ohira, Masahiro ^a   Oyama, Tomokazu ^a   Shirai, Kohji ^a  

^a National Hospital Organization   (Japan)

Author keywords

8 hydroxy 2' deoxyguanosine; Angiotensin II receptor blocker; Calcium channel blocker; Cardio ankle vascular index; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AMLODIPINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLMESARTAN; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

EID: 73249144824     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.497     Document Type: Article

References (26)

1. Kannel WB: Risk factors in hypertension. J Cardiovasc Pharmacol, 1989; 13: 4-10
2. The Japan Society of Hypertension: Guidelines for the Management of Hypertension (JSH 2004). 2004; 47-49
3. Bramwell JC, Hill AV: Velocity of the Pulse wave in Man. Proc Roy Soc, 1922; B: 298-306
4. Hayashi G, Sato M, Niimi H, Handa H, Moritake K, Okumura A: Analysis of vascular wall constitutive law with finite deformation theory. Medical Electronics and Biological Engineering, 1975; 13: 293-297
5. Hasegawa M: Fundamental research on human aortic pulse wave velocity. Jikei Medical Journal, 1970; 85: 742-760
6. Asmar R: Pulse wave velocity principles and measurement 25-55, in Arterial stiffness and pulse wave velocity edited by Asmar R, O'Rourke MF, Safar M, Elsevier Amsterdam, 1999
7. Kawasaki A, Takeuchi K, Hasegawa M, Yagi S, Nakayama S, Takayama Y: Noninvasive measurement of common carotid artery effect with echo phase tracking system. Journal of Japanese College of Angiology, 1982; 22: 241-248
8. Buntin CM, Silver FH: Noninvasive assessment of mechanical properties of peripheral arteries. Ann Biomed Eng, 1990; 18: 549-566
9. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
10. Yambe T, Meng X, Hou X, Wang Q, Sekine K, Shiraishi Y, Watanabe M, Tamaguchi T, Shibata M, Kuwayama T, Maruyama M, Konno S, Nitta S: Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantation. Biomed Pharmacother, 2005; 59(Suppl 1): S177-S179
11. Kubozono T, Miyata M, Ueyama K, Nagaki A, Otsuji Y, Kusano K, Kubozono O, Tei C: Clinical significance and reproducibility of new arterial distensibility index. Circ J, 2007; 71: 89-94
12. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72: 598-604
13. Shirai K, Nema T, Hiroh Y, Itoh Y, Miyashita Y, Watanabe H: Clinical efficacy of the direct assay method using polymers for serum high density lipoprotein cholesterols. J Clin Lab Anal, 1992; 11: 82-86
14. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T: Quantitative immunohistochemical determination of 8-hydroxy-2'deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest, 1997; 76: 365-374
15. Piechowski-Jóźwiak JB, Bogousslavsky J: Antihypertensive and lipid lowering treatment in stroke prevention: current state and future. Acta Neurol Belg, 2005; 105: 57-61
16. Okada K, Hirano T, Ran J, Adachi M: Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens Res, 2004; 27: 293-299
17. Baynes JW: Role of oxidative stress in development of complication in diabetes. Diabetes, 1991; 40: 405-412
18. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care, 1996; 19: 257-267
19. Baynes JW, Thorpe SR: The role of oxidative stress in diabetic complications. Curr Opin Endocrinol, 1997; 3: 277-284
20. Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA, 1989; 86: 9697-9701
21. Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E: Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care, 2003; 26: 1507-1512
22. Nakanishi S, Suzuki G, Kusunoki Y, Kimura K, Egusa G, Kohno N: Increasing of oxidative stress from mitochondria in type 2 diabetic patients. Diabetes Metab Res Rev, 2004; 20: 399-404
23. Ono H, Minatoguchi S, Watanabe K, Yamada Y, Mizukusa T, Kawasaki H, Takahashi H, Uno T, Tsukamoto T, Hiei K, Fujiwara H: Candesartan decreases carotid intimamedia thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res, 2008; 31: 271-279
24. Watson T, Goon PK, Lip GY: Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal, 2008; 10: 1079-1088
25. Fan J, Watanabe T: Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb, 2003; 10: 63-71
26. Lei YC, Hwang JS, Chan CC, Lee CT, Cheng TJ: Enhanced oxidative stress and endothelial dysfunction in streptozotocin-diabetic rats exposed to fine particles. Environ Res, 2005; 99: 335-343